FGF23 and left ventricular hypertrophy: Although Faul et al. showed in animal models and in isolated rat cardiomyocytes that treatment with FGF23 may directly cause pathological cardiac remodeling25, the administration of FGF23 has also been suggested to increase blood pressure26, which itself might contribute to left-ventricular hypertrophy.